272 related articles for article (PubMed ID: 2959230)
1. [In vivo platelet activation in mild arterial hypertension].
Guicheney P; Baudouin-Legros M; Meyer P
Arch Mal Coeur Vaiss; 1987 Jun; 80(6):808-11. PubMed ID: 2959230
[TBL] [Abstract][Full Text] [Related]
2. Beta-thromboglobulin and platelet aggregation in essential hypertension and the influence of prazosin therapy.
Okrucká A; Pechán J; Mikulecký M
Cor Vasa; 1990; 32(5):363-73. PubMed ID: 2149548
[TBL] [Abstract][Full Text] [Related]
3. Serotonin levels in hypertension.
Biondi ML; Agostoni A; Marasini B
J Hypertens Suppl; 1986 Apr; 4(1):S39-41. PubMed ID: 3457903
[TBL] [Abstract][Full Text] [Related]
4. Plasma beta-thromboglobulin to platelet factor 4 ratios as indices of vascular complications in essential hypertension.
Gomi T; Ikeda T; Yuhara M; Sakurai J; Nakayama D; Ikegami F
J Hypertens; 1988 May; 6(5):389-92. PubMed ID: 2968397
[TBL] [Abstract][Full Text] [Related]
5. Study of in vivo platelet activation in uncomplicated essential hypertension.
Guicheney P; Baudouin-Legros M; Meyer P
Life Sci; 1987 Feb; 40(7):615-21. PubMed ID: 2949131
[TBL] [Abstract][Full Text] [Related]
6. Plasma concentrations of platelet-specific proteins in different stages of essential hypertension: interactions between platelet aggregation, blood lipids and age.
Yamanishi J; Sano H; Saito K; Furuta Y; Fukuzaki H
Thromb Haemost; 1985 Aug; 54(2):539-43. PubMed ID: 2417354
[TBL] [Abstract][Full Text] [Related]
7. Increased platelet size and release reaction in essential hypertension.
Lande K; Os I; Kjeldsen SE; Westheim A; Hjermann I; Eide I; Gjesdal K
J Hypertens; 1987 Aug; 5(4):401-6. PubMed ID: 2959720
[TBL] [Abstract][Full Text] [Related]
8. Age and the platelet serotonin vasoconstrictor axis in essential hypertension.
Amstein R; Fetkovska N; Lüscher TF; Kiowski W; Bühler FR
J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S35-40. PubMed ID: 2459512
[TBL] [Abstract][Full Text] [Related]
9. Correlation between prolonged bleeding time and depletion of platelet dense granule ADP in patients with myelodysplastic and myeloproliferative disorders.
Malpass TW; Savage B; Hanson SR; Slichter SJ; Harker LA
J Lab Clin Med; 1984 Jun; 103(6):894-904. PubMed ID: 6233383
[TBL] [Abstract][Full Text] [Related]
10. Conditions influencing release of granule contents from human platelets in citrated plasma induced by ADP or the thrombin receptor activating peptide SFLLRN: direct measurement of percent release of beta-thromboglobulin and assessment by flow cytometry of P-selectin expression.
Rand ML; Perry DW; Packham MA; Gemmell CH; Yeo EL; Kinlough-Rathbone RL
Am J Hematol; 1996 Aug; 52(4):288-94. PubMed ID: 8701947
[TBL] [Abstract][Full Text] [Related]
11. Age, platelet serotonin kinetics and 5HT2-receptor blockade in essential hypertension.
Amstein R; Fetkovska N; Bühler FR
J Hum Hypertens; 1990 Aug; 4(4):441-4. PubMed ID: 2258891
[TBL] [Abstract][Full Text] [Related]
12. [Platelet aggregation in whole blood with the impedance method in subjects with non-complicated essential arterial hypertension].
Craveri A; Lanfredini M; Casati R; Citella C
Minerva Med; 1988 Jun; 79(6):441-6. PubMed ID: 2967926
[TBL] [Abstract][Full Text] [Related]
13. Effect of cold pressor test and awareness of hypertension on platelet function in normotensive and hypertensive women.
Mundal HH; Nordby G; Lande K; Gjesdal K; Kjeldsen SE; Os I
Scand J Clin Lab Invest; 1993 Oct; 53(6):585-91. PubMed ID: 8266004
[TBL] [Abstract][Full Text] [Related]
14. Anti-hypertensive drugs non-specifically reduce "spontaneous" activation of blood platelets.
Wilson J; Orchard MA; Spencer AA; Davies JA; Prentice CR
Thromb Haemost; 1989 Sep; 62(2):776-80. PubMed ID: 2535678
[TBL] [Abstract][Full Text] [Related]
15. [Changes in platelet function in patients with arterial hypertension].
Malý J; Pecka M; Pintérová E; Pidrman V; Bláha M; Siroký O; Jebavý L
Vnitr Lek; 1995 Jul; 41(7):458-61. PubMed ID: 7571480
[TBL] [Abstract][Full Text] [Related]
16. Platelet release of beta-thromboglobulin and platelet factor 4 and serotonin in plasma samples.
Ohkawa R; Hirowatari Y; Nakamura K; Ohkubo S; Ikeda H; Okada M; Tozuka M; Nakahara K; Yatomi Y
Clin Biochem; 2005 Nov; 38(11):1023-6. PubMed ID: 16098503
[TBL] [Abstract][Full Text] [Related]
17. Serotonin and platelet activation during treatment with isradipine.
Fetkovska N; Sebekova K; Fedelesova V; Dzurik R
J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S31-3. PubMed ID: 1720482
[TBL] [Abstract][Full Text] [Related]
18. Platelet activation indices and apolipoproteins in hypertensive patients.
Catalano M; Belletti S; Russo U; Aronica A; Carzaniga G; Seregni R; Libretti A
J Hum Hypertens; 1988 Oct; 2(3):195-7. PubMed ID: 2976836
[TBL] [Abstract][Full Text] [Related]
19. Effects of adrenaline infusion on serum thromboxane B2 and plasma beta-thromboglobulin levels in hypertensive and normotensive subjects.
Douma S; Zamboulis C; Karagiannis A; Sinakos Z
Nouv Rev Fr Hematol (1978); 1992; 34(1):73-8. PubMed ID: 1387933
[TBL] [Abstract][Full Text] [Related]
20. Blunted inhibition by insulin of agonist-stimulated calcium, pH and aggregatory responses in platelets from hypertensive patients.
Touyz RM; Schiffrin EL
J Hypertens; 1994 Nov; 12(11):1255-63. PubMed ID: 7868873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
